Ulta Lab Tests LogoContact Us

Category: Diabetes

September 19, 2026

FIB-4 Score Explained: Calculation and Age Cutoffs

Learn How to Calculate and Understand Your FIB-4 Score for Better Liver Health

Calculate the score correctly, apply age-appropriate thresholds, and understand when another assessment is needed. A FIB-4 score estimates the probability of advanced liver fibrosis using age, AST, ALT, and platelet count. It is a risk-stratification […]

Read More
September 18, 2026

MASLD Blood Tests: What Fatty Liver Testing Can Reveal

Understand MASLD and MASH, what initial blood tests can reveal, and when imaging or a separate fibrosis assessment is needed.

Understand fatty liver terminology, the purpose of initial blood tests, and when imaging or further assessment may be needed. MASLD blood tests help evaluate liver injury, metabolic risk, and possible alternative causes, but they cannot […]

Read More
September 18, 2026

MASLD Fibrosis Risk: Testing for Silent Liver Scarring

See how liver enzymes, platelets, FIB-4, ELF, and elastography help assess scarring risk before symptoms and guide follow-up.

How AST, ALT, platelets, A1C, lipids, and secondary fibrosis tests work together to guide evaluation and follow-up. MASLD fibrosis risk can be present even when liver enzymes fall within the laboratory reference interval. Metabolic dysfunction-associated […]

Read More
September 18, 2026

Adult-Onset Autoimmune Diabetes (LADA): When Type 2 Does Not Fit

How glucose, A1C, islet autoantibodies, C-peptide, and ketones help clarify diabetes type, remaining insulin production, and urgent risk. Adult-onset type 1 diabetes can initially resemble type 2 diabetes. In a slower-progressing presentation often called latent […]

Read More
September 17, 2026

Gout and Hyperuricemia: Why a Uric Acid Result Alone Does Not Diagnose—or Exclude—a Gout Flare

How serum urate, kidney function, metabolic risk, and crystal confirmation work together to clarify diagnosis and guide monitoring.

Gout is an inflammatory arthritis caused by deposits of monosodium urate crystals in and around joints. Hyperuricemia means that serum urate—often reported as “uric acid”—is elevated. The two are related, but they are not interchangeable: […]

Read More
September 10, 2026

Prediabetes and Type 2 Diabetes: Why A1C, Fasting Glucose, OGTT, Kidney, and Lipid Testing Must Be Read Together

How to read glucose, kidney, lipid, and liver results together and understand when additional testing or follow-up may be needed.

Glucose results tell you about blood sugar. Kidney, lipid, and liver results answer additional questions about your health. A person can have an improving A1C while urine albumin remains elevated, cholesterol-related risk persists, or liver […]

Read More
September 3, 2026

Can Fatigue Be an Early Sign of Diabetes? Symptoms, Blood Tests, and Other Causes

When unusual tiredness may point to high blood sugar, which tests can clarify the cause, and when another explanation is more likely.

Fatigue can occur with diabetes, but tiredness by itself cannot tell you whether your blood sugar is high. The most useful clues are the pattern of fatigue, the symptoms that appear with it, your risk […]

Read More
September 3, 2026

Obesity Is a Disease: BMI, Waist Size, and Lab Testing

How BMI and waist measurements fit with complication-focused evaluation—and why no blood test diagnoses obesity.

Editorial status: Draft for named medical and laboratory review. Product URLs are supported by current Ulta Lab Tests search and internal-link evidence but still require a final in-site canonical check before publication. Obesity is a […]

Read More
September 3, 2026

Leptin and Leptin Resistance: Function, Testing, and Limits

How leptin signals long-term energy availability, why high levels do not diagnose “leptin resistance,” and when serum leptin measurement may add useful clinical context.

What is leptin, and should it be tested for weight loss? Leptin is a hormone made mainly by fat cells. It carries information about stored energy to the brain, especially the hypothalamus, and helps coordinate […]

Read More
September 3, 2026

Cortisol, Stress, and Insulin Resistance: What the Evidence and Lab Tests Show

How cortisol affects glucose regulation, why everyday stress is not diagnosed with a cortisol test, and when endocrine testing belongs in care.

Direct Answer Cortisol helps the body make fuel available during physical or psychological demands. Sustained pathologic cortisol excess, as occurs in Cushing syndrome, can raise glucose, impair insulin action, increase blood pressure, and alter body-fat […]

Read More
September 2, 2026

Metabolic Syndrome Blood Tests: The 5 Criteria and What Results Mean

How waist circumference, blood pressure, fasting glucose, triglycerides, and HDL identify a connected cardiometabolic risk pattern.

Direct Answer Metabolic syndrome is a cluster of cardiometabolic risk factors, not a single blood-test result. A healthcare professional commonly identifies it when at least three of five findings are present: increased waist circumference, elevated […]

Read More
September 1, 2026

HOMA2-IR, HOMA2-%B, and HOMA2-%S Explained

What the fasting HOMA2 model can—and cannot—tell you about insulin sensitivity, insulin resistance, and beta-cell activity.

HOMA2-IR, HOMA2-%B & HOMA2-%S Explained Direct answer: HOMA2 is a nonlinear computer model, not a stand-alone blood test. From compatible fasting glucose with insulin or C-peptide, it estimates insulin sensitivity (HOMA2-%S), the reciprocal insulin-resistance index […]

Read More
August 28, 2026

High Triglycerides: Causes, ApoB, Remnant Cholesterol, and When ApoC-III Testing May Help

Understand why triglycerides rise, which tests should come first, and when ApoB, remnant cholesterol, direct LDL, or ApoC-III may add context.

Apolipoprotein B (ApoB) can add cardiovascular-risk information when the number of atherogenic particles may be underestimated by LDL cholesterol (LDL-C), particularly when triglycerides are above 200 mg/dL or diabetes is present. Calculated remnant cholesterol can […]

Read More
August 28, 2026

Heart Failure: How BNP, Kidney, Iron, Thyroid, and Metabolic Testing Complete the Diagnostic Picture

A patient-centered guide to how BNP or NT-proBNP fits with kidney function, electrolytes, iron status, thyroid function, and metabolic markers—and why no single test confirms heart failure.

Heart failure blood tests help answer different parts of the diagnostic puzzle. BNP or NT-proBNP can show that the heart is under increased wall stress, while kidney, electrolyte, blood-count, iron, thyroid, glucose, lipid, and liver […]

Read More
August 28, 2026

Hypertension Lab Tests: What Blood and Urine Testing Can Reveal After a High Reading

How Kidney Function, UACR, Electrolytes, Glucose, Lipids, Thyroid Testing, and Targeted Hormone Tests Help Explain the Risks Behind High Blood Pressure

A blood-pressure cuff detects elevated pressure inside your arteries. Hypertension lab tests answer different questions: they can help show whether high blood pressure is affecting the kidneys, whether glucose or lipid abnormalities are adding cardiovascular […]

Read More
August 27, 2026

What can I do to reduce the risk of type 2 diabetes?

Unlocking Prevention: Lab Testing as Your Guide to Reduce the Risk of Type 2 Diabetes

Type 2 diabetes cannot always be prevented, but many people can substantially lower or delay their risk. The most effective approach is to identify prediabetes early, build sustainable eating and activity habits, improve sleep, avoid […]

Read More
August 27, 2026

Is Falling Asleep After Eating a Sign of Diabetes?

What post-meal sleepiness can - and cannot - tell you about blood sugar, diabetes risk, and other common causes of fatigue.

Short answer: Falling asleep after eating is not, by itself, a reliable sign of diabetes. Post-meal sleepiness, also called postprandial somnolence, can occur because of a normal early-afternoon dip in alertness, insufficient sleep, a large […]

Read More
August 27, 2026

High A1C Levels Without Diabetes: Is It Possible

A high A1C can reflect true dysglycemia, red-blood-cell changes, or an assay interference. The right next step is confirmation—not assuming that you do or do not have diabetes.

It is possible to have a high A1C without an established diabetes diagnosis. An A1C of 5.7% to 6.4% is in the prediabetes range. An A1C of 6.5% or higher meets a diabetes diagnostic threshold, […]

Read More
August 27, 2026

Insulin Resistance Diet: Foods, Meals, and Lab Tests

A flexible, evidence-based approach to foods, meal planning, carbohydrate quality, and appropriate laboratory follow-up.

An insulin resistance diet is not one prescribed menu. It is a flexible eating pattern that emphasizes nonstarchy vegetables, fiber-rich carbohydrate foods, protein, and unsaturated fats while limiting sugary drinks, refined grains, and heavily processed […]

Read More
August 27, 2026

Diabetic Ketoacidosis and Ketone Testing: Why Beta-Hydroxybutyrate, Glucose, Electrolytes, and Acid-Base Results Must Be Read Together

How the DKA triad—ketosis, hyperglycemia or known diabetes, and metabolic acidosis—guides urgent diagnosis, severity assessment, and safe follow-up.

Diabetic ketoacidosis, or DKA, develops when insulin is too low for the body's needs and the liver rapidly produces acidic ketones. The resulting crisis is not defined by one abnormal value. Clinicians must establish three […]

Read More
August 27, 2026

Insulin Resistance as an Early-Warning System: Lab Patterns That Reveal Metabolic Strain

A focused guide to what A1C, fasting glucose, fasting insulin, triglycerides, HDL, ApoB, CMP, kidney, and selected inflammation markers can—and cannot—show before type 2 diabetes becomes obvious.

Insulin resistance can develop quietly. Early in the process, the pancreas may release more insulin to keep glucose in the usual range. A normal fasting glucose therefore does not always mean the glucose-insulin system is […]

Read More
August 27, 2026

Insulin Resistance and Type 2 Diabetes: Risk, Testing, and Prevention

How insulin resistance can progress to prediabetes and type 2 diabetes, which standard tests identify that progression, and what prevention can realistically accomplish.

Direct answer: Insulin resistance occurs when muscle, fat, and liver cells respond less effectively to insulin. The pancreas may compensate by releasing more insulin, allowing glucose to remain within the usual range for a time. […]

Read More
August 27, 2026

1,5-Anhydroglucitol (1,5-AG): When A1C May Miss Recent Glucose Spikes

An evidence-based guide to the narrow role of 1,5-AG as an adjunct—not a replacement—for A1C, plasma glucose, home monitoring, or continuous glucose data.

A1C and 1,5-anhydroglucitol do not compete for the same job. A1C is an established test for diabetes screening, diagnosis, and longer-term monitoring. 1,5-anhydroglucitol (1,5-AG) is a narrower adjunctive marker that may fall when glucose has […]

Read More
August 25, 2026

PMOS (Formerly PCOS) and Diabetes Risk: Why a Normal A1C May Not Tell the Whole Story

Learn why PMOS can increase impaired glucose tolerance and type 2 diabetes risk—and why OGTT, A1C, fasting glucose, lipids, and metabolic trends should be read together.

Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly called Polycystic Ovary Syndrome (PCOS), is both a reproductive and metabolic condition. The diabetes connection is important because glucose dysregulation can develop even when fasting glucose, A1C, or body […]

Read More
August 11, 2026

Diabetes and Prediabetes Blood Tests: A1C, Glucose, Insulin, and C-Peptide

Compare diabetes blood tests—including A1C, fasting glucose, OGTT, insulin, and C-peptide—for screening, diagnostic support, and ongoing monitoring.

Diabetes blood tests are not interchangeable. In nonpregnant adults, A1C, fasting plasma glucose, and the two-hour plasma glucose value from a 75-gram oral glucose tolerance test can be used for screening and diagnostic support. A […]

Read More
1 2 3
Copyright © 2013-2026 Ulta Lab Tests, LLC All Rights Reserved.